These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 23909452

  • 21. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [Abstract] [Full Text] [Related]

  • 22. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G, Davidson CR, Billings DL.
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [Abstract] [Full Text] [Related]

  • 23. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
    Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I.
    Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
    [Abstract] [Full Text] [Related]

  • 24. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    Fertil Steril; 2010 Oct; 94(5):1812-6. PubMed ID: 20004371
    [Abstract] [Full Text] [Related]

  • 25. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K, Njike V, Costales VC.
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [Abstract] [Full Text] [Related]

  • 26. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [Abstract] [Full Text] [Related]

  • 27. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 28. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.
    Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):185-9. PubMed ID: 22579228
    [Abstract] [Full Text] [Related]

  • 29. Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Panidis D.
    Gynecol Endocrinol; 2013 Mar; 29(3):250-3. PubMed ID: 23216335
    [Abstract] [Full Text] [Related]

  • 30. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 31. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
    Shishehgar F, Mirmiran P, Rahmati M, Tohidi M, Ramezani Tehrani F.
    BMC Endocr Disord; 2019 Sep 02; 19(1):93. PubMed ID: 31477085
    [Abstract] [Full Text] [Related]

  • 32. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
    Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A.
    J Clin Endocrinol Metab; 2015 Nov 02; 100(11):4048-58. PubMed ID: 26401593
    [Abstract] [Full Text] [Related]

  • 33. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, Busschbach JJ, Laven JS.
    Reprod Health; 2017 Mar 06; 14(1):34. PubMed ID: 28264692
    [Abstract] [Full Text] [Related]

  • 34. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P.
    Metabolism; 2006 Apr 06; 55(4):508-14. PubMed ID: 16546482
    [Abstract] [Full Text] [Related]

  • 35. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
    Hulchiy M, Nybacka Å, Sahlin L, Hirschberg AL.
    J Clin Endocrinol Metab; 2016 Feb 06; 101(2):561-71. PubMed ID: 26649621
    [Abstract] [Full Text] [Related]

  • 36. Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification.
    Poston WS, Reeves RS, Haddock CK, Stormer S, Balasubramanyam A, Satterwhite O, Taylor JE, Foreyt JP.
    Int J Obes Relat Metab Disord; 2003 Dec 06; 27(12):1486-93. PubMed ID: 14634679
    [Abstract] [Full Text] [Related]

  • 37. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E, Tarkun I, Cantürk Z, Cetınarslan B.
    Gynecol Endocrinol; 2011 Jul 06; 27(7):475-9. PubMed ID: 20586547
    [Abstract] [Full Text] [Related]

  • 38. The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.
    Chatzis P, Tziomalos K, Pratilas GC, Makris V, Sotiriadis A, Dinas K.
    Folia Med (Plovdiv); 2018 Dec 01; 60(4):512-520. PubMed ID: 31188761
    [Abstract] [Full Text] [Related]

  • 39. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
    Chen CI, Hsu MI, Lin SH, Chang YC, Hsu CS, Tzeng CR.
    Gynecol Endocrinol; 2015 Apr 01; 31(4):264-8. PubMed ID: 25423261
    [Abstract] [Full Text] [Related]

  • 40. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis.
    Graff SK, Mario FM, Ziegelmann P, Spritzer PM.
    Int J Clin Pract; 2016 Jun 01; 70(6):450-61. PubMed ID: 27228266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.